ArticleOncotarget2022

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma.

Sujatha Muralidharan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.